» Articles » PMID: 11331070

Involvement of All-trans-retinoic Acid in the Breakdown of Retinoic Acid Receptors Alpha and Gamma Through Proteasomes in MCF-7 Human Breast Cancer Cells

Overview
Date 2001 May 2
PMID 11331070
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Most studies have reported an up-regulation of retinoic acid receptor (RAR) mRNA expression by all-trans retinoic acid (RA). We aimed to study the effect of RA on RAR protein levels in MCF-7 human breast cancer cells. Incubation of these cells with 10(-6) M RA induced a rapid breakdown of both RARalpha and RARgamma in spite of the accumulation of their mRNAs. Proteasome specific inhibitors blocked the RA-induced breakdown of RARs. Furthermore, RA enhanced the formation of the complex between RARalpha and ubiquitin in a concentration- and time-dependent manner, suggesting the involvement of ubiquitin and proteasome in this reaction. Retinoid X receptor alpha (RXRalpha) was also decreased, albeit to a lesser extent, in RA-treated cells. Use of synthetic receptor agonists and antagonists clearly showed that the effect of the retinoid on the breakdown of the retinoid receptors is receptor-ligand agonist-dependent and blunted by the antagonist. An electrophoretic mobility shift assay, using nuclear extracts from RA-treated cells, showed that a reduction in complex formation with hormone response elements correlated with the reduction of RAR and RXR protein. These data suggest that RA induces the breakdown of RARs through a process involving ubiquitination and that this phenomenon causes a reduction in the formation of DNA-receptor complexes.

Citing Articles

All-trans retinoic acid targets gastric cancer stem cells and inhibits patient-derived gastric carcinoma tumor growth.

Nguyen P, Giraud J, Staedel C, Chambonnier L, Dubus P, Chevret E Oncogene. 2016; 35(43):5619-5628.

PMID: 27157616 DOI: 10.1038/onc.2016.87.


Retinoids induce cellular senescence in breast cancer cells by RAR-β dependent and independent pathways: Potential clinical implications (Review).

Shilkaitis A, Green A, Christov K Int J Oncol. 2015; 47(1):35-42.

PMID: 25997921 PMC: 4485653. DOI: 10.3892/ijo.2015.3013.


An ATRActive future for differentiation therapy in AML.

Johnson D, Redner R Blood Rev. 2015; 29(4):263-8.

PMID: 25631637 PMC: 4494875. DOI: 10.1016/j.blre.2015.01.002.


Synergy against PML-RARa: targeting transcription, proteolysis, differentiation, and self-renewal in acute promyelocytic leukemia.

Augusto Dos Santos G, Kats L, Pandolfi P J Exp Med. 2013; 210(13):2793-802.

PMID: 24344243 PMC: 3865469. DOI: 10.1084/jem.20131121.


Retinoic acid receptor alpha is associated with tamoxifen resistance in breast cancer.

Johansson H, Sanchez B, Mundt F, Forshed J, Kovacs A, Panizza E Nat Commun. 2013; 4:2175.

PMID: 23868472 PMC: 3759040. DOI: 10.1038/ncomms3175.